Loading...
Loading...
Application UK00911643244 · Dead
| Application Number | UK00911643244 |
| Status | Dead |
| Owner | Intrexon Corporation |
| Filed | 2013-03-11 |
| Registered | 2013-09-06 |
| Renewal Due | 2023-03-11 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
INTREXON BETTER DNA has a current status of Dead.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Chemicals, biochemicals and reagents for use in industry and science; Chemicals, namely, chemicals for use in industry and science, chemicals for use in biochemical and chemical industry; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; Chemicals, biochemicals and reagents for industrial, scientific, laboratory and research use, namely receptor proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for pharmaceutical, medical, veterinary, agricultural and industrial applications; Chemicals and chemical reagents, namely ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and protein receptors for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development.
Chemical preparations for medical and veterinary purposes; chemical reagents for medical and veterinary purposes; biochemical preparations for medical and veterinary purposes; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes; cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research.
Development of new technology for others in the field of genetics and biotechnology; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development services for others in the fields of genetics and biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development of products in the field of genetics and biotechnology, namely genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells for medical or clinical use; Manufacturing and custom synthesis of genetically engineered DNA, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical and laboratory use; Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; gene therapy services for others for product development and scientific research purposes, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use.
Medical services; Medical services, namely, gene therapy services.
Technology transfer services, namely, licensing and transfer of intellectual property.
'INTREXON BETTER DNA' is a dead trademark on the UK IPO register, owned by Intrexon Corporation. The application (UK00911643244) was filed on 11 March 2013 and registered on 6 September 2013. The registration is set to expire on 11 March 2023.
This mark is recorded under multiple classes: Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services); Class 45 (legal, security & personal services).
The trademark is represented by Bénédikte HATTIER.
UK trademark UK00911643244 for the mark 'INTREXON BETTER DNA' in Class 1, 5, 42, 44, 45 is recorded on the UK IPO register as owned by Intrexon Corporation. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00911643244 for the mark 'INTREXON BETTER DNA' as dead.
UK trademark UK00911643244 for the mark 'INTREXON BETTER DNA' is recorded in Class 1 (chemicals for industrial, scientific & agricultural use); Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services); Class 45 (legal, security & personal services). The filed specification reads: Class 1: Chemicals, biochemicals and reagents for use in industry and science; Chemicals, namely, chemicals for use in industry and science, chemicals for use in biochemical and chemical industry; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and r…
UK trademark UK00911643244 for the mark 'INTREXON BETTER DNA' was filed at the UK IPO on 11 March 2013 and registered on 6 September 2013.
UK trademark UK00911643244 for the mark 'INTREXON BETTER DNA' is currently recorded as valid until 11 March 2023, at which point it will need to be renewed with the UK IPO to remain in force.
Bénédikte HATTIER is listed as the attorney / representative of record for UK trademark UK00911643244 for the mark 'INTREXON BETTER DNA' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.